Publisher Correction: Mendelian randomisation study of the relationship between vitamin D and risk of glioma.

Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
23 May 2019
Historique:
entrez: 24 5 2019
pubmed: 24 5 2019
medline: 24 5 2019
Statut: epublish

Résumé

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.

Identifiants

DOI: 10.1038/s41598-019-43787-2 PMID: 31118477 PMC: PMC6531429
pubmed: 31118477
doi: 10.1038/s41598-019-43787-2
pii: 10.1038/s41598-019-43787-2
pmc: PMC6531429
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

7924

Commentaires et corrections

Type : ErratumFor

Auteurs

Hannah Takahashi (H)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.

Alex J Cornish (AJ)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
ORCID: 0000-0002-3966-3501

Amit Sud (A)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
ORCID: 0000-0002-6133-0164

Philip J Law (PJ)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
ORCID: 0000-0001-9663-4611

Ben Kinnersley (B)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
ORCID: 0000-0003-1783-6296

Quinn T Ostrom (QT)

Case Comprehensive Cancer Center, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.

Karim Labreche (K)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
ORCID: 0000-0002-3164-9406

Jeanette E Eckel-Passow (JE)

Division of Biomedical Statistics and Informatics, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

Georgina N Armstrong (GN)

Department of Medicine, Section of Epidemiology and Population Sciences, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA.

Elizabeth B Claus (EB)

School of Public Health, Yale University, New Haven, Connecticut, USA.
Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Dora Il'yasova (D)

Department of Epidemiology and Biostatistics, School of Public Health, Georgia State University, Atlanta, Georgia, USA.
Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.
Cancer Control and Prevention Program, Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, USA.
ORCID: 0000-0003-4290-6794

Joellen Schildkraut (J)

Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.
Cancer Control and Prevention Program, Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, USA.

Jill S Barnholtz-Sloan (JS)

Case Comprehensive Cancer Center, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
ORCID: 0000-0001-6190-9304

Sara H Olson (SH)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Jonine L Bernstein (JL)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Rose K Lai (RK)

Departments of Neurology and Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

Minouk J Schoemaker (MJ)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.

Matthias Simon (M)

Department of Neurosurgery, University of Bonn Medical Center, Sigmund-Freud-Str. 25, 53105, Bonn, Germany.

Per Hoffmann (P)

Human Genomics Research Group, Department of Biomedicine, University of Basel, Basel, Switzerland.
Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany.

Markus M Nöthen (MM)

Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany.
Institute of Human Genetics, University of Bonn School of Medicine & University Hospital Bonn, Bonn, Germany.

Karl-Heinz Jöckel (KH)

Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Stephen Chanock (S)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, USA.

Preetha Rajaraman (P)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, USA.

Christoffer Johansen (C)

Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
ORCID: 0000-0002-4384-206X

Robert B Jenkins (RB)

Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, Minnesota, USA.

Beatrice S Melin (BS)

Department of Radiation Sciences, Umeå University, Umeå, Sweden.

Margaret R Wrensch (MR)

Department of Neurological Surgery, School of Medicine, University of California, San Francisco, California, USA.
Institute of Human Genetics, University of California, San Francisco, California, USA.

Marc Sanson (M)

Sorbonne Universités UPMC Univ Paris 06, INSERM CNRS, U1127, UMR 7225, ICM, F-75013, Paris, France.
AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de neurologie 2-Mazarin, Paris, France.

Melissa L Bondy (ML)

Department of Medicine, Section of Epidemiology and Population Sciences, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA.

Clare Turnbull (C)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
William Harvey Research Institute, Queen Mary University, London, UK.
Guys and St Thomas Foundation NHS Trust, Great Maze Pond, London, UK.

Richard S Houlston (RS)

Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. richard.houlston@icr.ac.uk.
Division of Molecular Pathology, The Institute of Cancer Research, London, UK. richard.houlston@icr.ac.uk.

Classifications MeSH